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Abstract 
Atlantic lumpfish (Cyclopterus lumpus L.) is used as a biological delousing agent for sea lice 
(Lepeophtheirus salmonis K.) infestations in Norwegian aquaculture. Here we present a study 
on the antibody response and vaccine side effects after intramuscular and intraperitoneal 
injection of lumpfish with two vaccines. Both vaccines contained bacterial antigens from 
atypical Aeromonas salmonicida A-layer type V and VI, Vibrio anguillarum serotype O1 and 
Moritella viscosa sp., but one vaccine contained a vegetable oil-based adjuvant while the 
other contained a mineral oil-based adjuvant. Intramuscular injection of the mineral oil-based 
vaccine caused a high acute mortality of fish within 48 hours after immunization. 
Intraperitoneal injection of the mineral oil-based vaccine resulted in a lower severity of intra-
abdominal side effects than the vegetable oil-based vaccine. Intramuscular injection of the 
mineral oil-based vaccine resulted in a significantly higher antibody response against A. 
salmonicida when compared to controls and the vegetable oil-based vaccine group. The 
antibody response was poor against V. anguillarum and M. viscosa for all groups. Our results 
indicate that intramuscular injection of oil-based vaccines might be feasible for providing 
immunological protection for Atlantic lumpfish against bacterial diseases, especially atypical 
A. salmonicida, but more work is required to identity optimal adjuvants.  
Keywords: Atlantic lumpfish, intramuscular injection, antibody response, oil adjuvant, side 
effect, vaccination.  
Introduction 
Atlantic lumpfish, Cyclopterus lumpus L., is a marine fish commonly used as “cleaner fish” 
for biological delousing of salmon louse, Lepeophtheirus salmonis (Krøyer), infestations on 
farmed Atlantic salmon, Salmo salar L., in Norway. Commercial production of lumpfish has 
increased rapidly, from just above 430.000 individuals in 2012 to nearly 12 million 
individuals in 2015 (Norwegian Directorate of Fisheries, 2016). Disease after sea transfer is 
currently a major challenge, especially bacterial infections caused by atypical Aeromonas 
salmonicida, Vibrio anguillarum, Vibrio ordalii, Pseudomonas anguilliseptica, Pasteurella 
sp. and Tenacibaculum spp. (Hjeltnes et al., 2016). Such bacterial infections may lead to mass 
mortality of the lumpfish, and a national survey conducted in 2013 reported a total mortality 
of 48 % among the localities included, where 75 % were caused by bacterial infections 
(Nilsen et al., 2014). Similar findings were also reported in a study of increased mortality of 
lumpfish during autumn/late summer of year 2015, were bacterial agents was confirmed in 
nearly 80 % of the case materials and atypical furunculosis and vibriosis was considered to be 
the most important causes of mortality (Bornø et al., 2016). The authors suggested improved 
vaccines and vaccination strategies as an important step in reducing future mortality events of 
lumpfish. 
Lumpfish have previously been immunized with Vibrio ordalii, Vibrio anguillarum, two 
strains of atypical Aeromonas salmonicida, and a Pasteurella-like bacteria, showing a higher 
presence of specific antibodies (IgM) in immunized fish, except for fish immunized with the 
V. ordalii agent (Ronneseth et al., 2015). Currently, there are only four commercially 
available vaccines for lumpfish against bacterial diseases (reviewed in Johansen et al. (2016)), 
two regular and two autogenous. The autogenous vaccines consists of a dip vaccine, 
containing Vibrio splendidus, Vibrio logei, Vibrio ordalii and Vibrio anguillarum O1 
antigens, and an injection vaccine containing two isolates of atypical Aeromonas salmonicida, 
Vibrio anguillarum O1 and, in some instances, Moritella viscosa sp. antigens. Similarly, the 
two regular vaccines consists of a dip vaccine, containing Vibrio anguillarum O1 and O2a and 
b antigens, and an injection vaccine, ALPHA MARINE® micro 4, containing Vibrio 
anguillarum O1 and O2a and b and atypical Aeromonas salmonicida antigens. ALPHA 
MARINE® micro 4 was recently pulled from the market, and replaced by the injection 
vaccine AMARINE® micro 4-2, containing atypical Aeromonas salmonicida (A-layer type 3 
and 6), in addition to Listonella anguillarum (syn. Vibrio anguillarum) serotype O1 and O2a 
antigens (Ø.B. Vågnes 2016, personal communication, April).  
Despite of more than 60 % of the lumpfish being vaccinated when transferred to sea, either by 
injection or dip vaccine, or a combination of these two, several investigators request improved 
vaccines or vaccination methods for cleanerfish (Bornø et al., 2016). The pelvic fins of 
lumpfish form suction discs which they use to strongly anchor themselves to rocks or other 
surfaces (Davenport, 1985). This can potentially be a problem during administration of 
injectable vaccines, which are normally deposited into the abdominal cavity, causing more 
handling of the fish (Vestvik, 2014). One other alternative could be to inject the vaccine at a 
different and more easily accessible administration site, such as the dorsal musculature.  
Up to now, the vaccine strategy includes intraperitoneal injection of vaccines. Since it may be 
favorable to immunize fish through intramuscular injection, we hypothesized that lumpfish 
immunized via intramuscular injection are well tolerated, and induce comparable antibody 
response compared to intraperitoneal immunization.  
  
Materials and methods 
Fish 
Atlantic lumpfish (Cyclopterus lumpus L.) with mean weight of 5 and/or 10 grams was 
provided by Norsk Oppdrettsservice AS in Flekkefjord. The fish were kept in the rearing 
facilities at Havbruksstasjonen i Tromsø AS. The fish were fed Amber Neptun, obtained from 
Skretting AS, and fed ad libitum throughout the experiment. The fish were kept in circular 
140 L tanks with continuous flow of sea water. The water temperature was about 9 ᵒC four 
days prior to the start, and was gradually heated to and kept at 10 ᵒC (± 1 ᵒC) throughout the 
experiment. The fish were kept under constant 24:0 hour light:dark conditions, and water 
temperature, fish appetite, behavior and mortality was checked daily, while O2 saturation was 
checked weekly. The fish displayed no signs of disease or mortality at the start of the 
experiment. Prior to the start of the experiment, the fish were sorted in two different size 
groups to ensure that each individual had a minimum body weight of either 10 g (± 0,5 g) in 
size group 1, or 5 g (± 1,0 g) in size group 2. Feeding was withheld 48 hours prior to 
immunization, to reduce the risk of accidental injection into the internal organs e.g. a faeces-
filled intestine, and was resumed 24 hours after immunization. The experiment was approved 
by the Norwegian Animal Research Authority (NARA). 
 
Vaccine antigens  
Two experimental vaccines containing different oil adjuvants were specifically produced and 
kindly donated by Vaxxinova Norway AS for this study. Both vaccines contained four 
formalin-inactivated bacterial antigens: Aeromonas salmonicida A-layer type V, Aeromonas 
salmonicida A-layer type VI, Vibrio anguillarum serotype O1 and Moritella viscosa sp. 
Vaccine 1 was prepared using a vegetable oil-based adjuvant (unspecified), while vaccine 2 
was prepared using a mineral oil-based adjuvant (paraffin).  
 
Vaccine formulation 
The bacterial isolates was initially manually mixed to the desired concentration (unspecified) 
in PBS containing 1,5% NaCl. Further mixing was conducted by using an IKA T18 
Ultraturrax homogenizer until both vaccines contained a final formulation of 70% oil and 
30% water (w/o). Any further information regarding the adjuvants and bacterial isolates used 
for the vaccines has been withheld due to competitive considerations. 
 
Immunization/vaccination of lumpfish 
The fish were anesthetized with Finquel vet. (Western Chemical Inc., USA), individually 
weighed and tagged using a Visible Implant Fluorescent Elastomer kit (Northwest Marine 
Technology Inc., USA) prior to immunization. The fish were immunized by intraperitoneal 
(ip.) or intramuscular (im.) injection of 0,05 ml per fish of vaccine 1 (VO) or vaccine 2 (MO), 
whereas control groups received phosphate-buffered saline (PBS). The im. injection was done 
on the left side of the dorsal hump, just vertically for the pectoral fins, and the ip. injection 
was done in the ventral midline, in the central area between the vent opening and the caudal 
edge of the suction disc. Injection was performed using a Microfish 0,05 ml hand-operated 
reusable syringe (Kaycee Veterinary products LTD, UK), and 0,5 x 4 mm and 0,5 x 3 mm 
vaccination needles (Unimed SA, Switzerland) for size group 1 and size group 2, respectively. 
Groups of 62 fish were injected im. and groups of 25 fish were injected ip. Due to high acute 
mortality observed after im. injection of size group 1 lumpfish with the mineral oil-based 
vaccine, size group 2 lumpfish were not im. injected with this vaccine. After injection, the fish 
were kept in an anesthetic-free tank until recovery, before being transferred back to their 
original holding tanks for the rest of the experiment. Fish to be sampled on the same day as 
immunization was kept in a separate 50 L plastic tank for recovery and kept there until the 
time of sampling. 
Scoring of vaccine side effects 
Lumpfish immunized via im. and ip. injection were evaluated for possible vaccine side 
effects. Weight and length was measured in both groups and the number of dead fish was 
registered during the full length of the study. Ip. injected fish were scored according to the 
Speilberg scoring system (Midtlyng et al., 1996). The scoring system was modified to fit 
lumpfish. In short, the following modifications were done; a separate scoring scale for 
melanisation of abdominal organs and abdominal wall, and a separate scoring scale for 
vaccine residues, as described by Aunsmo et al. (2008) and Fredriksen & Grip (2012).   
Sampling from immunized lumpfish 
Parallel series of 4 fish were randomly collected 1 h, 4 h, 1 d, 2 d, 4 d, 7 d and 28 d post 
immunization (dpi.) and series of 10 fish were collected 14 d and 42 d post immunization. 
The remaining fish were collected at 84 dpi. The fish were killed by a sharp blow to the head, 
immediately followed by blood sampling. Peripheral blood was collected from vena caudalis 
of the lumpfish into clot activator tubes (BD, USA), and kept on ice until serum preparation 
for ELISA. Individual body weight and body length was registered, and vaccine side effects 
(Speilberg score) was evaluated for ip. immunized fish prior to organ sampling. From im. 
immunized fish, samples were dissected from head kidney, spleen, gills, and the integument 
and underlying muscular tissues surrounding the injection site. From ip. immunized fish, 
organ samples were dissected from head kidney, gills, spleen and the gastro-intestinal tract, 
including the pyloric caeca. All samples were put on 10% formalin. Due to the decision to not 
im. inject size group 2 lumpfish with the mineral oil-based vaccine, only samples from fish 
collected in size group 1 was used for the rest of the study.  
 
Enzyme-linked immunosorbent assay (ELISA) 
A whole cell/competitive ELISA was used to determine serum reactivity to formalin-
inactivated bacterial antigens (Aeromonas salmonicida A-layer type V, Aeromonas 
salmonicida A-layer type VI, Vibrio anguillarum serotype O1 and Moritella viscosa sp.). All 
antigens were kindly donated by Vaxxinova Norway AS. Briefly, microtiter plates 
(MaxiSorp, Nunc) were coated for 5 minutes with 100 µl of a 0,1% poly-L-lysine solution 
(Sigma) in coating buffer. Further, 100 µl ultrasonicated or whole cell bacteria (108 cellmL-1) 
in 50 mM carbonated-bicarbonate buffer (pH 9,6) were added per well before the plates were 
centrifuged and incubated at 4 ᵒC over night. Thereafter, all plates were saturated with 5% dry 
milk in PBST (phosphate buffered saline with Tween 20, pH 7,3) and incubated at room 
temperature for 2 hours. Lumpfish sera were diluted 1:100 and 1:200 in 0,5% dry milk in 
PBST, 100 µl well-1, and incubated over night at 4 ᵒC. Bound antibodies were detected by 
incubations at room temperature with polyclonal rabbit-anti-lumpfish IgM (produced 
according to Bilal et al.(2016)), (2h), followed by incubation with goat-anti rabbit IgG 
conjugated with alkaline phosphate (Sigma) in 0,5% dry milk in PBST (1h). Finally, the 
substrate p-nitrophenyl phosphate (Sigma) in substrate solution (0,1 M glycine, pH 10,4, with 
1 mM MgCl2 and 1 mM ZnCl2), followed by incubation for 30 min at room temperature in 
dark. After the final incubation the optical density (OD) of the plates were immediately 
analyzed with a spectrophotometer (VersaMax Absorbance Microplate Reader; Molecular 
Devices, LLC, USA) at a wavelength of 405 nm. 
 
Preparation of samples for histology and immunohistochemistry 
Sections of muscle tissue from the injection site of lumpfish 1 h, 4 h, 1 day, 2 days, 7 days, 21 
days and 42 days after im. injection were fixed in 10% formalin for 24 h at room temperature, 
transferred to 70% EtOH and thereafter embedded in paraffin. Sections (3 µm) were cut and 
stained with haematoxylin and eosin (HE) for histology. Immunohistochemistry (IHC) for V. 
anguillarum serotype O1 was performed on dewaxed and rehydrated paraffin sections. The 
primary antibody, raised in rabbit was a gift from Nofima AS, Tromsø. Staining was 
performed using a goat-anti rabbit IgG conjugated with alkaline phosphate (Sigma), fast red 
visualization system and haematoxylin counterstaining.  
Slides were microscopically analyzed by using an Axio Lab.A1 microscope (Carl Zeiss 
Microscopy GmbH, Germany). Images were acquired by using a Moticam 5.0 MP camera 




All collected data were treated and analyzed statistically by using the software Prism version 
7.02 (GraphPad Software Inc., USA). Group means were compared by using one-way 
ANOVA with Tukey Multiple Comparison test, and differences were considered significant 




Mortality was monitored daily during the course of the experiment and were used to calculate 
accumulated mortality rates for all fish groups. Within 48 hours after immunization a total of 
fifteen lumpfish, im. injected with the mineral oil-based vaccine, died (30,6% mortality) (Fig. 
1). The majority of these fish died within the first 8 hours after vaccination. A total of four 
lumpfish im. injected by the vegetable oil-based vaccine died (8,2% mortality); the last 
mortality was registered at 63 dpi. (not shown). No mortalities were registered for the control 
group (PBS) or the ip. injected fish. 
It has been shown for several aquacultured fish species that vaccination may result in a 
decreased growth (Berg et al., 2006a). As such, we analysed the lumpfish growth following 
im. and ip. immunization by measuring body weight at the start of immunization on day 0, 
followed by 21 and 42 dpi. At day 42 our results showed an average of 27% reduction in 
mean weight of  in the VO and MO group compared to the control group (PBS) after im. 
injection (Fig. 2). However, the difference between vaccine injected and PBS injected fish 
were not significant (p=0,07). At day 84 the VO group showed a 59% significant reduction 
compared to the MO group (p=0,03). At day 21 there were no differences in mean weight. For 
ip. injected fish our results demonstrated a significant reduction (p=0,02) of 37% in mean 
weight for the VO group at day 21 and a non-significant reduction (p=0,39) of 17% for the 
MO group compared to the PBS group, (Fig. 3). At day 42 there were a significant reduction 
(34%) (p=0,03) of mean weight for the VO group and a non-significant reduction (p=0,26) of 
19% for the MO group compared to the fish that received PBS. Finally, at day 84 both the VO 
and the PBS group showed a significant reduction of 38% (p=0,04) and 39% (p=0,04), 
respectively, compared to the MO group.  
The Speilberg score is a well established tool for evaluating side effects after ip. injection of 
oil-based vaccines in Atlantic salmon (Berg et al., 2006a). In our study we assessed the degree 
of adhesions between viscera and abdominal wall, visible melanin pigmentation of viscera 
and abdominal wall/fillet, and vaccine residues of ip. injected lumpfish at 21, 42 and 84 dpi. 
by using a modified Speilberg score. The highest severity of intra-abdominal adhesions was 
seen in the VO fish at all sampling times, significantly different compared to the MO group at 
21 (p=0,04) and 42 (p<0,05) dpi. (Fig. 4). At day 84 the mean scores had reached its highest 
point at 5,2 and 4,6 for the VO and the MO group, respectively, the results were, however, not 
significantly different (p=0,27). No melanisation of viscera or abdominal wall/fillet was 
observed (Table 1). Both vaccinated groups showed a reduction in mean score for vaccine 
residues over time, where the MO group were significantly lower than the VO group at 21 
(p<0,05) and 42 (p<0,05) dpi. (Table 1). At day 84 the MO group showed a higher mean 
score than the VO group, but the difference was not significant (p=0,30). No intra-abdominal 
adhesions, melanisations or residual vaccines were observed in the control group (PBS). 
The Atlantic lumpfish possess an adaptive immune system and produce specific antibodies 
upon immunization (Ronneseth et al., 2015), but whether im. immunization induces robust 
antibody response is an open question. We measured the specific IgM response of pooled and 
individual serum samples from both im. and ip. injected lumpfish against atypical A. 
salmonicida A-layer type V and VI, V. anguillarum serotype O1 and M. viscosa sp. at 21, 42 
and 84 dpi. by ELISA. Our results suggested a robust IgM response against A. salmonicida 
type V and VI for both im. and ip. injected fish with the mineral oil-based vaccine at 42 and 
84 dpi. (Fig. 6). However, the IgM response was low against V. anguillarum O1 and M. 
viscosa sp., and close to the same level displayed by the control fish (PBS) after both im. and 
ip. injection (results not shown). Fish immunized by the vegetable oil-based vaccine showed 
generally low IgM responses after both im. and ip. injection, except for one group on 84 dpi. 
(Fig. 5). This group showed a high IgM response against A. salmonicida type V after ip. 
injection of the vegetable oil-based vaccine.  
ELISA was used to measure the individually specific IgM responses of ten fish sampled from 
each group at 42 dpi, against atypical A. salmonicida A-layer type V and VI, V. anguillarum 
serotype O1 and M. viscosa sp. For lumpfish immunized by the mineral oil-based vaccine, our 
results indicated significantly high IgM responses for both im. and ip. injected fish against A. 
salmonicida type V and VI (p<0,05) when compared to the control groups (PBS) (Fig. 8). The 
im. injected fish showed less variation between high and low IgM responders than the ip. 
injected fish. Lumpfish immunized by the vegetable oil-based vaccine demonstrated low IgM 
responses against all antigens mentioned, except for a single individual fish in the ip. injected 
control group (PBS) against both A. salmonicida type V and VI (Fig. 7). 
On gross examination of im. injected lumpfish we observed residual vaccine around the 
injection site, and along the dorsal side of the fish during early sampling (results not shown).  
As such, we performed histological evaluation of transversal sections of the skin and 
muscular tissue. In vaccinated fish, local reactions in the tissue around the injection site were 
noted, primarily inflammation of the connective tissue between the dermis and muscular layer 
of the skin. Granuloma-like structures were noted in some sections. The majority of local 
reactions were observed as early as 48 hours post immunization, while no clear distinction 
between VO and MO groups could be established (results not shown).    
Immunohistochemistry was used to detect residual vaccine antigens of V. anguillarum 
serotype O1 in cross sections of skin and muscle tissue from im. injected lumpfish sampled at 
42 d.p.i. The antigen was present in sections from fish injected with both the vegetable oil-
based (Fig. 9b) and the mineral oil-based vaccine (Fig. 9c), and was mostly detected in the 
connective tissue between the dermis and muscular layer of the skin. In addition, signs of 
inflammation could be observed in several sections. No antigen was detected in any sections 
from the control fish (PBS) (Fig. 9a).    
  
Discussion 
In this study we have immunized Atlantic lumpfish with two injection vaccines containing 
different oil adjuvants. To the best of our knowledge, this is the first study to examine 
antibody response and fish welfare after intramuscular injection of oil-based vaccines in 
Atlantic lumpfish. 
A total of 10 lumpfish died within 8 hours, with the first fish within 1,5 hours, after 
intramuscular injection of the mineral oil-based vaccine. From 8 to 48 hours another 5 fish 
died. The fish that survived the first 48 hours showed no signs of adverse reactions or changed 
behavior. The mortality was much lower for fish injected with the vegetable oil-based 
vaccine, were 3 fish died within 48 hours after injection. No mortalities were registered 
throughout the experiment for the control group (PBS) and ip. injected fish. To our 
knowledge, acute mortality after im. injection of oil-based vaccines in fish have not been 
previously reported. Treasurer and Cox (2008) investigated whether the dorsal median sinus 
(dms), the adipose tissue running under the dorsal fin of the fish, could be used as an 
alternative route to intraperitoneal vaccination of Atlantic salmon. They noted that dead 
Atlantic salmon having received dorsal median sinus injection of oil-based vaccines showed 
signs of muscular damage at the injection site. They concluded that the vaccine had been 
administered too deep, and that this was the most probable cause of the observed cumulative 
mortality of 0,5-1% for the dms group. Ip. injected fish in the same experiment reached a 
mortality level of 1-5%, but this appeared to be primarily caused by Saprolegnia infections. 
Fløgum (2016) reported that the vegetable oil-based vaccine used in vaccination of ballan 
wrasse did not appear to cause increased mortality. However, although these reports indicated 
that adjuvant formulation might affect post-immunization mortality after im. injection, the 
exact cause of the observed acute mortality in our study is unclear.  
Fish ip. injected by the vegetable oil-based vaccine exhibited a significantly higher score of 
intra-abdominal adhesions, than fish injected with the mineral oil-based vaccine. This was in 
contrast to what was expected, since non-mineral oils are considered to be well tolerated and 
produce less side effects than traditional mineral oils (Aucouturier et al., 2001, Tafalla et al., 
2013). Low or moderate adherence formation after ip. injection of non-mineral oil-based 
vaccines have been observed in several fish species, such as Atlantic salmon (Salmo salar L.) 
(Midtlyng et al., 1996), Atlantic halibut (Hippoglossus hippoglossus L.) (Bowden et al., 
2003), turbot (Psetta maxima L.) (Sitja-Bobadilla et al., 2008) and ballan wrasse (Labrus 
bergylta L.) (Fløgum, 2016). However, our results are in agreement with the observations of 
Rønsholdt and McLean (1999), who reported adhesion scores of up to grade 6 in rainbow 
trout (Oncorhynchus mykiss L.) at seven weeks post ip. injection with a monovalent vaccine 
containing a metabolizable oil adjuvant. Poppe and Breck (1997) reported in a case study high 
adhesion scores appearing several months after vaccination, where Atlantic salmon were ip. 
injected with a multivalent vaccine adjuvanted with a mixture of vegetable and animal oils. 
Although the authors listed several possible factors to explain the results, the exact cause for 
the development of intra-abdominal lesions seen in our study is unknown. 
None of the vaccinated fish displayed any signs of melanisation, which results in dark 
pigmentation of abdominal organs or the abdominal wall. We have also noted the same results 
up to 18 weeks post vaccination in an earlier immunization trial using a divalent oil-based 
injection vaccine for lumpfish (Erkinharju 2015, personal observation, May 12). Melanisation 
after intraperitoneal vaccination has been observed in other fish species, such as Atlantic 
salmon (Midtlyng et al., 1996, Berg et al., 2006b), rainbow trout (Ronsholdt and McLean, 
1999) and Atlantic cod (Mutoloki et al., 2008). However, according to Maira et al. (2008) 
melanin formation does not seem to be present at any degree in Atlantic cod and Fløgum 
(2016) observed no signs of pigmentation in vaccinated ballan wrasse. Our results are in 
agreement with these observations. 
Our results demonstrated a high specific antibody (IgM) response against atypical A. 
salmonicida A-layer type V and VI for lumpfish at 42 and 84 d.p.i. This was confirmed by 
statistical analysis of individual samples collected at 42 d.p.i., were vaccinated fish had 
significantly higher mean values than the controls (PBS). Successful vaccination of other fish 
species, such as Atlantic salmon and rainbow trout, against atypical variants of A. salmonicida 
have proven to be very difficult and given highly variable results, as reviewed by Gudding 
(2014). However, other researchers have shown that it is possible to provide protection and 
strong antibody response for both spotted wolfish (Anarchicas minor O.) (Lund et al., 2002), 
ballan wrasse (Biering et al., 2016) and Atlantic lumpfish (Ghebretnsae, 2015) against 
atypical variants of A. salmonicida through vaccination, and are in accordance with our 
observations.   
Lumpfish immunized by the vegetable oil-based vaccine displayed a low specific IgM 
response against all antigens at every sampling point, except for ip. injected fish against A. 
salmonicida A-layer type V at 84 d.p.i. This was confirmed by statistical analysis of 
individual samples collected at 42 d.p.i., were vaccinated fish was in general not significantly 
different from the controls (PBS). Very few studies have examined the antibody responses 
after vaccination of fish with non-mineral oil-based adjuvants. However, our results are in 
agreement with the observations of Bowden et al. (2003), who reported low antibody titers of 
Atlantic halibut up to several months after vaccination. Sitja-Bobadilla et al. (2008) detected 
low numbers of serum antibodies in turbot injected with a multivalent vaccine prior to 
challenge. A vegetable oil-based vaccine was also used for vaccination of ballan wrasse in the 
study reported by Fløgum (2016); however, the specific antibody response was not examined. 
The specific IgM response against V. anguillarum serotype O1 and M. viscosa sp. was lower 
than for both the A-layer types of A. salmonicida, and did not increase over time. Similar 
results have been observed for Atlantic cod, where V. anguillarum appeared to induce a lower 
and more varied antibody response when compared to A. salmonicida (Lund et al., 2006, 
Schroder et al., 2009). We have also observed a low specific IgM response in lumpfish during 
an earlier immunization trial, by using ip. injection of a divalent vegetable oil-based vaccine 
containing Vibrio salmonicida antigens (Erkinharju 2015, personal observation, July 14). 
However, Ghebretnsae (2015) demonstrated a near similar antibody response for Atlantic 
lumpfish against both A. salmonicida and V. anguillarum after ip. injection. However, 
vaccination of Atlantic salmon have also resulted in significant protection against V. 
anguillarum and M. viscosa (Colquhoun and Lillehaug, 2014).  
There was no significant differences in the specific IgM responses between im. and ip. 
injected fish for all bacterial antigens. To our knowledge, no studies have compared the 
immune responses of teleost fish after im. and ip. injection of vegetable oil-based or mineral 
oil-based vaccines. However, our results are in agreement with the observations by Treasurer 
and Cox (2008) on Atlantic salmon, who reported no significant differences between the 
antibody responses of dms and ip. injected fish. Haugland et al. (2005) investigated the 
expression profiles of inflammatory and immune-related genes of Atlantic salmon after both 
im. and ip. injection of a multi-component vegetable oil-based vaccine, and discovered highly 
variable individual responses to vaccination. However, no further analysis of the immune 
response was reported. 
Our analysis of serum samples from fish sampled at 42 d.p.i. displayed an apparent individual 
variation between high and low specific IgM responders against atypical A. salmonicida A-
layer type V and type VI, after both ip. and im. injection of the mineral oil-based vaccine. In a 
different study, Grontvedt and Espelid (2004) reported significant antibody response and 
protection after vaccination and challenge of spotted wolfish with atypical variants of A. 
salmonicida, although the individual responses could vary from none to high. However, more 
work is needed to investigate whether the immunization described in our study would provide 
sufficient protection towards development of disease in Atlantic lumpfish.  
Immunohistochemical analysis on cross sections of skin and muscle tissue from im. injected 
lumpfish detected the presence of V. anguillarum serotype O1 antigens, confirming residual 
vaccine was still present in the tissues at 42 d.p.i. Several inflammatory cells was observed 
near the encapsulated vaccine antigens in sections from fish injected with both vaccines. This 
indicates that an inflammatory response had been triggered, which is necessary for the proper 
development of an immune response in teleost fish after injection of oil-based vaccines (Berg 
et al., 2006a).  
To conclude, our study indicates that intramuscular injection of oil-based vaccines might be 
feasible for providing immunological protection for Atlantic lumpfish against bacterial 
disease, especially against atypical A. salmonicida, but more work is required to identify 
adjuvants that provide optimal fish welfare in addition to immunological protection. 
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Figure 1. Percentage accumulated mortality of intramuscularly injected fish. Number at the 
start was 49 fish for all groups. VO=vegetable oil group, MO=mineral oil group, 
PBS=phosphate buffered saline group. 
 
Figure 2. Comparison of mean weight (g) ± S.D. for intramuscularly injected fish at the start 
of vaccination on day 0 (n=62), and at 21 days (n=10 for VO and PBS, n=4 for MO), 42 days 
(n=10) and 84 days (n=2 for VO, n=4 for MO and n=5 for PBS) post vaccination. 
Combination of different letters (a, b and c) indicates significant (p < 0,05) differences 
between groups. VO=vegetable oil group, MO=mineral oil group, PBS=phosphate buffered 
saline group. 
 
Figure 3. Comparison of mean weight (g) ± S.D. for intraperitoneally injected fish at the start 
of vaccination on day 0 (n=25), and at 21 days (n=10), 42 days (n=10) and 84 days (n=5) post 
vaccination. Combination of different letters (a, b and c) indicates significant (p < 0,05) 
differences between groups. VO=vegetable oil group, MO=mineral oil group, PBS=phosphate 
buffered saline group. 
 
Figure 4. Comparison of mean Speilberg score of adherences ± S.D. at day 21 (n=10), day 42 
(n=10) and day 84 (n=5) post vaccination for intraperitoneally injected fish. Combination of 
different letters (a and b) indicates significant (p < 0,05) differences between groups. VO= 
vegetable oil group, MO=mineral oil group, PBS=phosphate buffered saline group. 
 
Table 1. Mean score of melanisation of abdominal organs and abdominal wall/fillet, and 
mean score of vaccine residues for intraperitoneally injected fish at day 21 (n=10), day 42 
(n=10) and day 84 (n=5) post vaccination. VO=vegetable oil group, MO=mineral oil group, 
PBS= phosphate buffered saline group. 
  Day 21  Day 42 Day 84 
  VO MO PBS VO MO PBS VO MO PBS 
Melanisation of abdominal organs 0 0 0 0 0 0 0 0 0 
Melanisation of abdominal wall/fillet 0 0 0 0 0 0 0 0 0 
Vaccine residues 2 0,7 0 1,6 0 0 0,4 0,8 0 
 
 
Figure 5. Comparison of specific antibody (IgM) responses against Aeromonas salmonicida 
V (a) and Aeromonas salmonicida VI (b), from lumpfish im. and ip. injected with the 
vegetable oil-based vaccine. Values are presented as ELISA readings (mean O.D. at 405nm) 
of pooled serum samples diluted 1:100. Number of fish (n) for IM groups: day 21 (n=10), day 
42 (n=10) and day 84 (n=2 for VO and n=5 for PBS). Number of fish (n) for IP groups: day 
21 (n=10), day 42 (n=10), day 84 (n=5). VO=vegetable oil group, PBS=phosphate buffered 
saline group, IM=intramuscular, IP=intraperitoneal. 
 
Figure 6. Comparison of specific antibody (IgM) responses against Aeromonas salmonicida 
V (a) and Aeromonas salmonicida VI (b), from lumpfish im. and ip. injected with the mineral 
oil-based vaccine. Values are presented as ELISA readings (mean O.D. at 405nm) of pooled 
serum samples diluted 1:100. Number of fish (n) for IM groups: day 21 (n=10 for PBS and 
n=4 for MO), day 42 (n=10) and day 84 (n=4 for MO and n=5 for PBS). Number of fish (n) 
for IP groups: day 21 (n=10), day 42 (n=10), day 84 (n=5). MO=mineral oil group, 
PBS=phosphate buffered saline group, IM=intramuscular, IP=intraperitoneal. 
 
Figure 7. Comparison of specific antibody (IgM) responses against Aeromonas salmonicida 
V (a) and Aeromonas salmonicida VI (b), from lumpfish im. and ip. injected with the 
vegetable oil-based vaccine, at 42 days post vaccination. Values are presented as ELISA 
readings (mean O.D. ± S.D.) of individual serum samples diluted 1:100 (n=10). Combination 
of different letters (a, b and c) indicates significant (p < 0,05) differences between groups. 
VO=vegetable oil group, PBS=phosphate buffered saline group, IM=intramuscular, 
IP=intraperitoneal. 
 
Figure 8. Comparison of specific antibody (IgM) responses against Aeromonas salmonicida 
V (a) and Aeromonas salmonicida VI (b), from lumpfish im. and ip. injected with the mineral 
oil-based vaccine, at 42 days post vaccination. Values are presented as ELISA readings (mean 
O.D. ± S.D.) of individual serum samples diluted 1:100 (n=10). Combination of different 
letters (a, b and c) indicates significant (p < 0,05) differences between groups. VO=vegetable 
oil group, PBS=phosphate buffered saline group, IM=intramuscular, IP=intraperitoneal. 
Figure 9. Immunohistochemistry images of lumpfish intramuscularly injected with PBS (a), 
vegetable oil-based vaccine (b) and mineral oil-based vaccine (c) at 42 days post 
immunization. Note the presence of red stained V. anguillarum O1 antigens in the vaccinated 
fish. Scale bar = 100 µm. Image shown at 10 x magnification. 
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